Stimulation of angiogenesis by fibroblast derived exosomes
US-12310991-B2 · May 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ichim Thomas patents
Ichim Thomas is listed as an inventor on 73 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ichim Thomas |
| Total patents | 73 |
| First publication | Sep 24, 2020 |
| Latest publication | May 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Induction of Antigen Specific Immunological Tolerance Using Inducible Pluripotent Stem Cell Derived Veto Cells
US-2024374723-A1 · Nov 14, 2024 · US
Fibroblast delivery of tumor inhibitory agents
US-2024293469-A1 · Sep 5, 2024 · US
Fibroblast delivery of tumor inhibitory agents
US-2024293468-A1 · Sep 5, 2024 · US
Means and methods of preventing or reversing aging
US-2024287459-A1 · Aug 29, 2024 · US
Stimulation of angiogenesis by fibroblast derived exosomes
US-2024269193-A1 · Aug 15, 2024 · US
Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
US-2024261336-A1 · Aug 8, 2024 · US
Augmentation of fibroblast regenerative activity
US-2024263140-A1 · Aug 8, 2024 · US
Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
US-11975030-B2 · May 7, 2024 · US
Methods and compositions for alopecia treatment using fibroblasts and fibroblast-derived products
US-2024139257-A1 · May 2, 2024 · US
Recent patents
Latest publications not already listed above.
Augmentation of fibroblast regenerative activity
US-11959102-B2 · Apr 16, 2024 · US
Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
US-11878037-B2 · Jan 23, 2024 · US
Methods and compositions for allergy and asthma treatment using fibroblasts
US-2024000850-A1 · Jan 4, 2024 · US
Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
US-2023407258-A1 · Dec 21, 2023 · US
Fibroblast and tlr activated fibroblast treatment of viral induced acute respiratory distress syndrome
US-2023346848-A1 · Nov 2, 2023 · US
Augmentation of fibroblast therapeutic activity by complement blockade and/or inhibition
US-2023340416-A1 · Oct 26, 2023 · US
Dental and periodontal application of fibroblasts
US-2023321154-A1 · Oct 12, 2023 · US
Reduction of covid-19 coagulopathy and other inflammation-associated coagulopathies by administration of fibroblasts
US-2023270792-A1 · Aug 31, 2023 · US
Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
US-11732239-B2 · Aug 22, 2023 · US
Augmentation of fibroblast cell therapy efficacy by microbiome manipulation
US-2023248777-A1 · Aug 10, 2023 · US
Fibroblast based therapy for treatment of parkinson's disease
US-2023242873-A1 · Aug 3, 2023 · US
Augmentation of fibroblast therapy using extracorporeal shock wave therapy and/or transfection of biologically relevant molecules
US-2023218757-A1 · Jul 13, 2023 · US
Fibroblasts as a regenerative cellular source for the treatment of blindness
US-2023220336-A1 · Jul 13, 2023 · US
Fibroblast therapy for prevention and reversion of aneurysms
US-2023201270-A1 · Jun 29, 2023 · US
Gene modified fibroblasts for therapeutic applications
US-2023193205-A1 · Jun 22, 2023 · US
Treatment of erectile dysfunction by fibroblast administration
US-2023193204-A1 · Jun 22, 2023 · US
Treatment of ovarian failure using regenerative cells
US-2023181647-A1 · Jun 15, 2023 · US
Prevention of recurrent miscarriages through administration of fibroblasts and fibroblast-educated paternal cells
US-2023167410-A1 · Jun 1, 2023 · US
Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereof
US-2023165918-A1 · Jun 1, 2023 · US
Immunotherapeutic methods and compositions for targeting cancer fibroblasts
US-2023149466-A1 · May 18, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Figene Llc | 72 |
| Creative Medical Tech Inc | 1 |
| Spinalcyte Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K35/33 | 63 |
| C12N5/0656 | 44 |
| A61K45/06 | 29 |
| C12N2500/02 | 16 |
| A61K35/28 | 15 |